Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype

NCT04474197 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha1-Antitrypsin Deficiency

Interventions

DRUG: VX-864
DRUG: Placebo

Sponsor

Vertex Pharmaceuticals Incorporated